Dallah Healthcare's revenues jump 22%, supported by expansions and Vision 2030
Dallah Healthcare, one of the leading private healthcare companies in the Kingdom of Saudi Arabia, announced its financial results for the first quarter ending March 31, 2026. The results showed strong growth in revenues and visit numbers, reflecting the success of its expansion strategy and the strength of its brand, which is characterized by quality and reliability in the Saudi market.
Strong financial performance reflects operational growth
during the first quarter of 2026, 21.7% reaching SAR 1.013 billion, compared to SAR 832.75 million in the same quarter of the previous year. This growth is primarily attributed to a significant increase in the number of patients visiting the Group’s facilities, which jumped by 27.5% to 936,000 visits, compared to 734,000 visits in the same period last year. Recent operational expansions and acquisitions, particularly of Dallah Al Khobar Hospital and Dallah Al Ahsa Hospital, played a pivotal role in bolstering this positive performance.
General context: A promising healthcare sector under Vision 2030
This strong performance comes within the context of the comprehensive transformation underway in the Kingdom’s healthcare sector, a key pillar ofSaudi Vision 2030.The Vision aims to increase the private sector’s contribution to providing and facilitating access to high-quality healthcare services, thereby creating a fertile and growth-oriented investment environment. Leading companies like Dallah Healthcare are capitalizing on this trend by expanding their network of facilities and diversifying their services to meet the growing demand for specialized healthcare.
Impact of acquisitions and decline in net profit
Despite strong revenue growth, net profit attributable to shareholders decreased by 45.7% to SAR 84.52 million, compared to SAR 155.56 million in the same quarter of 2025. The company explained that this decrease was primarily due to a one-time event in the corresponding quarter of the previous year, in which the company recorded investment gains of SAR 51 million resulting from an in-kind contribution to a real estate fund. Additionally, financing costs and operating expenses increased as a result of consolidating the results of the newly acquired hospitals within the Group's consolidated financial statements.
An optimistic outlook
Commenting on the results, Eng. Tariq Al-Qasabi, Chairman of the Board of Directors of the company, praised the strong operational performance and the ability of “Dallah Healthcare” to achieve revenues exceeding one billion riyals in the current quarter, stressing that the net profit achieved is in line with the company’s estimated budget for 2026. Al-Qasabi expressed his optimism for the future, noting that the company continues to benefit from its strategic expansions, whether in existing or acquired facilities, in addition to future projects such as Al-Ared Hospital north of Riyadh, and investments in digital transformation to improve the patient experience and operational efficiency, which will add further momentum to the company’s future growth.
